Kong, Yuanyuan

Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta-analysis

Lv, T., Chen, S., Li, M., Zhang, D., Kong, Y., & Jia, J. (2021) · Journal of Gastroenterology and Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 165

APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis

You, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 133

Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort

Wang, H., Wang, Y., Li, X., Deng, X., Kong, Y., Wang, W., & Zhou, Y. (2022) · Cardiovascular Diabetology

Metabolomics and Mass Spectrometry StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 34

Meta-analysis of antinuclear antibodies in the diagnosis of antimitochondrial antibody-negative primary biliary cholangitis

Zhang, Q., Liu, Z., Wu, S., Duan, W., Chen, S., Ou, X., You, H., Kong, Y., & Jia, J. (2019) · Gastroenterology Research and Practice

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 28

Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients

Zhao, X., Wang, Y., Lai, R., Wang, X., Yu, Y., Li, M., Zhao, H., Ma, Z., Li, M., Guo, T., et al. (2024) · Hepatology Communications

Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug Reactions

Cited by 12